Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;90:1162-1167

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rinder, H. M.
Right arrow Articles by Smith, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rinder, H. M.
Right arrow Articles by Smith, B. R.

Circulation, Vol 90, 1162-1167, Copyright © 1994 by American Heart Association


ARTICLES

Platelet alpha-granule release in cocaine users

HM Rinder, KA Ault, PI Jatlow, TR Kosten and BR Smith
Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Conn. 06520-8035.

BACKGROUND: Cocaine use has been associated with arterial occlusion resulting from platelet-rich thrombi and with an accelerated, often atypical atherosclerotic lesion that could be ascribed to platelet activation and platelet alpha-granule release. METHODS AND RESULTS: Using a flow cytometric method to quantitate the percent of circulating activated platelets in whole blood (those that express the alpha- granule membrane protein P-selectin), we found that 5 of 25 samples from 12 long-term cocaine users had a baseline level of circulating activated platelets > 3 SD (range, 19% to 60%) above the mean (4.4 +/- 3.7%, mean +/- 1 SD) for 85 nonusers (sample n = 130). This subset resulted in a significantly higher mean baseline level of circulating activated platelets (11.8 +/- 14.4%) for all cocaine users (P = .01). By contrast, cocaine and its metabolites, at concentrations documented as obtainable during in vivo cocaine use (10(-7) to 10(-5) mol/L), had no effect on in vitro platelet activation or aggregation, either directly or in concert with platelet agonists. However, in experiments in which cocaine users received blinded infusions of placebo or cocaine, the mean percent of circulating activated platelets rose significantly (P < .05) after infusion of either placebo (peak 77 +/- 31%) or cocaine (peak 65 +/- 28%), the latter at doses resulting in peak plasma cocaine levels averaging < 10(-6) mol/L. CONCLUSIONS: Long- term cocaine use in some subjects is intermittently associated with high basal levels of circulating platelets that have undergone alpha- granule release. The inability of cocaine and its metabolites at concentrations of 10(-7) to 10(-5) mol/L to cause platelet P-selectin expression in vitro in this study, coupled with the acute increase in circulating activated platelets observed in vivo after either cocaine or placebo infusion, suggests that in vivo platelet alpha-granule release associated with cocaine use may occur through indirect rather than direct effects of the drug.


This article has been cited by other articles:


Home page
CirculationHome page
J. McCord, H. Jneid, J. E. Hollander, J. A. de Lemos, B. Cercek, P. Hsue, W. B. Gibler, E. M. Ohman, B. Drew, G. Philippides, et al.
Management of Cocaine-Associated Chest Pain and Myocardial Infarction: A Scientific Statement From the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology
Circulation, April 8, 2008; 117(14): 1897 - 1907.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S. D Treadwell and T. G Robinson
Cocaine use and stroke
Postgrad. Med. J., June 1, 2007; 83(980): 389 - 394.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S L Greene, P I Dargan, and A L Jones
Acute poisoning: understanding 90% of cases in a nutshell
Postgrad. Med. J., April 1, 2005; 81(954): 204 - 216.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. A. Lange and L. D. Hillis
Cardiovascular Complications of Cocaine Use
N. Engl. J. Med., August 2, 2001; 345(5): 351 - 358.
[Full Text] [PDF]


Home page
HeartHome page
C M Heesch, C R Wilhelm, J Ristich, J Adnane, F A Bontempo, and W R Wagner
Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans
Heart, June 1, 2000; 83(6): 688 - 695.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
A. J. Siegel, M. B. Sholar, J. H. Mendelson, S. E. Lukas, M. J. Kaufman, P. F. Renshaw, J. C. McDonald, K. B. Lewandrowski, F. S. Apple, J. J. Stec, et al.
Cocaine-Induced Erythrocytosis and Increase in von Willebrand Factor: Evidence for Drug-Related Blood Doping and Prothrombotic Effects
Arch Intern Med, September 13, 1999; 159(16): 1925 - 1929.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M J A Williams, N J Restieaux, and C J S Low
Myocardial infarction in young people with normal coronary arteries
Heart, February 1, 1998; 79(2): 191 - 194.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
J. E. Hollander, D. E. Brooks, and S. M. Valentine
Assessment of Cocaine Use in Patients With Chest Pain Syndromes
Arch Intern Med, January 12, 1998; 158(1): 62 - 66.
[Abstract] [Full Text] [PDF]